← All trials
NCT05304169
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 14, 2017
- Primary completion
- Jun 15, 2018
- Completion date
- Jun 15, 2020
- First posted
- Mar 31, 2022
- Last posted
- Mar 31, 2022
- Enrollment
- 48
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Zodiac Produtos Farmaceuticos S.A.Lead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.